Skip to main content
SpringerLink
Log in
Book cover

Inflammation and Retinal Disease: Complement Biology and Pathology

  • Conference proceedings
  • © 2010

Overview

Editors:
  1. John D. Lambris

    1. Department Of Pathology Laboratory Of, Medicine, University Of Pennsylvania, Philadelphia, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Anthony P. Adamis

    1. , Department of Ophthalmology and Visual S, University of Illinois at Chicago, Chicago, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Comprehensive look at the pathology and biology of retinal inflammation
  • Written by current, respected opthamologists and eye researchers
  • Reports on age-related degeneration, gene-associations, and other physiological pathways to retinal inflammation
  • Includes supplementary material: sn.pub/extras

Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 703)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (11 papers)

  1. Front Matter

    Pages i-xiii
    Download chapter PDF

  2. The Case for Complement and Inflammation in AMD: Open Questions

    • Natalia Karagianni, Anthony P. Adamis
    Pages 1-7

  3. The Role of Complement in AMD

    • Peter F. Zipfel, Nadine Lauer, Christine Skerka
    Pages 9-24

  4. Multiple Interactions of Complement Factor H with Its Ligands in Solution: A Progress Report

    • Stephen J. Perkins, Ruodan Nan, Azubuike I. Okemefuna, Keying Li, Sanaullah Khan, Ami Miller
    Pages 25-47

  5. Genetic Control of Complement Activation in Humans and Age Related Macular Degeneration

    • Laura A. Hecker, Albert O. Edwards
    Pages 49-62

  6. Bisretinoids of RPE Lipofuscin: Trigger for Complement Activation in Age-Related Macular Degeneration

    • Janet R. Sparrow
    Pages 63-74

  7. The Role of the Classical Complement Cascade in Synapse Loss During Development and Glaucoma

    • Allison M. Rosen, Beth Stevens
    Pages 75-93

  8. A Role for Complement in Glaucoma?

    • Lizhen Ren, John Danias
    Pages 95-104

  9. The ATP-Binding Cassette Transporter ABCA4: Structural and Functional Properties and Role in Retinal Disease

    • Yaroslav Tsybovsky, Robert S. Molday, Krzysztof Palczewski
    Pages 105-125

  10. Suppression of Drusen Formation by Compstatin, a Peptide Inhibitor of Complement C3 activation, on Cynomolgus Monkey with Early-Onset Macular Degeneration

    • Zai-Long Chi, Tsunehiko Yoshida, John D. Lambris, Takeshi Iwata
    Pages 127-135

  11. A Targeted Inhibitor of the Complement Alternative Pathway Reduces RPE Injury and Angiogenesis in Models of Age-Related Macular Degeneration

    • Bärbel Rohrer, Qin Long, Beth Coughlin, Brandon Renner, Yuxiang Huang, Kannan Kunchithapautham et al.
    Pages 137-149

  12. Complement Depletion with Humanized Cobra Venom Factor in a Mouse Model of Age-Related Macular Degeneration

    • David C. Fritzinger, Robin Dean, Carol Meschter, Katina Wong, Roman Halter, Jürgen Borlak et al.
    Pages 151-162

  13. Back Matter

    Pages 163-167
    Download chapter PDF
Back to top

Keywords

About this book

Numerous studies have pointed to the key role of complement in the pathogenesis of retinal disease, particularly age-related macular degeneration (AMD). Reports about new gene associations and links to other physiological pathways are emerging almost on a weekly base. Several promising clinical candidates covering a wide area of potential treatment applications are in the pipelines of both industrial and academic groups. This indicates an increasing interest in complement as a therapeutic target. In view of these exciting discoveries, scientists from around the world convened at the First Aegean Conferences Conference on Inflammation and Retinal Disease: Complement Biology and Pathology (June 10–17, 2007) in Crete, Greece, to discuss recent advances in this rapidly-evolving field. This volume represents a collection of topics on the functions of complement in eye diseases, pathophysiology, protein structures, and complement therapeutics discussed during the conference. Our sincere thanks to the contributing authors for the time and effort they have devoted to writing what I consider exceptionally informative chapters in a book that will have a significant impact on the complement field. We would also like to express my thanks to Rodanthi Lambris for her assistance in collating the chapters and preparing the documents for publication and I gratefully acknowledge the generous help provided by Dimitrios Lambris in managing the organization of this meeting. Finally, I also thank Andrea Macaluso of Springer Publishers for her supervision in this book’s production. John D. Lambris Anthony P.

Editors and Affiliations

  • Department Of Pathology Laboratory Of, Medicine, University Of Pennsylvania, Philadelphia, USA

    John D. Lambris

  • , Department of Ophthalmology and Visual S, University of Illinois at Chicago, Chicago, USA

    Anthony P. Adamis

Bibliographic Information

  • Book Title: Inflammation and Retinal Disease: Complement Biology and Pathology

  • Editors: John D. Lambris, Anthony P. Adamis

  • Series Title: Advances in Experimental Medicine and Biology

  • DOI: https://doi.org/10.1007/978-1-4419-5635-4

  • Publisher: Springer New York, NY

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 2010

  • Hardcover ISBN: 978-1-4419-5634-7Published: 25 August 2010

  • Softcover ISBN: 978-1-4614-2648-6Published: 13 October 2012

  • eBook ISBN: 978-1-4419-5635-4Published: 14 August 2010

  • Series ISSN: 0065-2598

  • Series E-ISSN: 2214-8019

  • Edition Number: 1

  • Number of Pages: XIV, 170

  • Topics: Ophthalmology

Publish with us

Policies and ethics

Back to top

Search

Navigation